AJ Lanigan: Sure. In Reality, pharma firms are building big dollars with remedies like Keytruda and Opdivo that offer with PD-1 and PD-L1. Here’s the super great component: visualize checkpoints as traffic indicators. You don’t want an immune program that’s operating wild similar to a freight practice around a cliff. waiting for link from Social Bookmarking